Xiongwei Cai

1.3k total citations
30 papers, 785 citations indexed

About

Xiongwei Cai is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Xiongwei Cai has authored 30 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Xiongwei Cai's work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xiongwei Cai is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Xiongwei Cai collaborates with scholars based in China, United States and United Kingdom. Xiongwei Cai's co-authors include Nancy A. Speck, Kai Tan, Philip J. Mason, Li Teng, Jingping Ge, Ashish Kumar, D. Gary Gilliland, Long Gao, Trista E. North and Yan Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Xiongwei Cai

29 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiongwei Cai China 14 466 258 231 198 129 30 785
Marloes R. Tijssen United Kingdom 16 431 0.9× 430 1.7× 143 0.6× 100 0.5× 94 0.7× 29 852
Koichi R. Katsumura United States 18 578 1.2× 257 1.0× 170 0.7× 76 0.4× 87 0.7× 24 863
Saiphone Webb United States 12 444 1.0× 98 0.4× 170 0.7× 91 0.5× 66 0.5× 16 703
Tiphaine Bouriez‐Jones United Kingdom 10 166 0.4× 150 0.6× 278 1.2× 77 0.4× 44 0.3× 14 547
Tara MacRae Canada 14 466 1.0× 374 1.4× 159 0.7× 46 0.2× 67 0.5× 25 735
Yoon-A Kang United States 10 335 0.7× 450 1.7× 416 1.8× 44 0.2× 50 0.4× 11 814
Roy Drissen United Kingdom 11 656 1.4× 225 0.9× 242 1.0× 50 0.3× 46 0.4× 17 929
Hiroshi Shin Japan 8 197 0.4× 125 0.5× 107 0.5× 160 0.8× 117 0.9× 9 516
Cristina Mirantes Spain 13 279 0.6× 93 0.4× 142 0.6× 36 0.2× 112 0.9× 17 595
Megan Fuller Canada 13 418 0.9× 81 0.3× 120 0.5× 29 0.1× 202 1.6× 20 670

Countries citing papers authored by Xiongwei Cai

Since Specialization
Citations

This map shows the geographic impact of Xiongwei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongwei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongwei Cai more than expected).

Fields of papers citing papers by Xiongwei Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiongwei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongwei Cai. The network helps show where Xiongwei Cai may publish in the future.

Co-authorship network of co-authors of Xiongwei Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiongwei Cai. A scholar is included among the top collaborators of Xiongwei Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiongwei Cai. Xiongwei Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Fei, Longfei Yin, Xiongwei Cai, et al.. (2025). Multi-modal fusion model combines SERS spectroscopy and clinicopathological features to predict neoadjuvant therapy response in breast cancer. Analytica Chimica Acta. 1378. 344677–344677. 1 indexed citations
2.
Chen, Li, Yue Chen, Haodong Huang, et al.. (2024). CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer. Cell Death and Disease. 15(9). 662–662. 2 indexed citations
3.
Wunderlich, Mark, Xiongwei Cai, Feng Zhang, et al.. (2023). Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor. Leukemia. 37(10). 2073–2081. 3 indexed citations
4.
Jiang, Yi, Yan Qin, Zexuan Yan, et al.. (2023). ZYX promotes invasion and metastasis of gastric cancer cells via WNK1/SNAI1axis. Genes & Diseases. 11(2). 564–567. 1 indexed citations
5.
Wang, Chen, Xiongwei Cai, Weinan Wang, et al.. (2023). A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation. Blood Advances. 7(11). 2590–2605. 10 indexed citations
7.
Li, Changzheng, Binghuo Wu, Yishan Li, et al.. (2022). Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis. Cell stem cell. 29(7). 1119–1134.e7. 59 indexed citations
8.
Chen, Fang, et al.. (2022). Bioinformatics Analysis Reveals Hub Genes That May Reduce Inflammation and Complications After Cardiopulmonary Bypass. The Heart Surgery Forum. 25(2). E243–E252. 1 indexed citations
9.
Zeng, Ping, et al.. (2022). The Regulation of miR-206 on BDNF: A Motor Function Restoration Mechanism Research on Cerebral Ischemia Rats by Meridian Massage. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 7 indexed citations
10.
Chen, Huang, Zheng Yang, Jianhui Ma, et al.. (2021). Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer. Frontiers in Oncology. 11. 674933–674933. 14 indexed citations
11.
Luo, Cheng, et al.. (2021). Circular RNA PVT1 silencing prevents ischemia-reperfusion injury in rat by targeting microRNA-125b and microRNA-200a. Journal of Molecular and Cellular Cardiology. 159. 80–90. 31 indexed citations
12.
Liu, Songsong, Junfeng Zhang, Liangyu Yin, et al.. (2020). The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Cell Death and Disease. 11(6). 412–412. 29 indexed citations
13.
Chen, Mengyue, Yanzhou Wang, Cheng Chen, et al.. (2019). FAT1 inhibits the proliferation and metastasis of cervical cancer cells by binding β-catenin.. PubMed. 12(10). 3807–3818. 16 indexed citations
14.
Cai, Xiongwei, Yi Zheng, & Nancy A. Speck. (2018). A Western Blotting Protocol for Small Numbers of Hematopoietic Stem Cells. Journal of Visualized Experiments. 9 indexed citations
15.
Zhao, Chuntao, Feng Zhang, Xiongwei Cai, et al.. (2017). mTOR Restricts Chromatin Access and Genomic Activity to Maintain Hematopoietic Stem Cell Quiescence and Engraftment. Blood. 130. 2416–2416. 1 indexed citations
16.
Cai, Xiongwei, Long Gao, Li Teng, et al.. (2015). Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. Cell stem cell. 17(2). 165–177. 164 indexed citations
17.
Li, Yan, Virginie Esain, Li Teng, et al.. (2014). Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production. Genes & Development. 28(23). 2597–2612. 198 indexed citations
18.
Corpora, Takeshi, Liya Roudaia, Wei Chen, et al.. (2010). Structure of the AML1-ETO NHR3–PKA(RIIα) Complex and Its Contribution to AML1-ETO Activity. Journal of Molecular Biology. 402(3). 560–577. 15 indexed citations
19.
Park, Sang‐Ho, Wei Chen, Tomasz Cierpicki, et al.. (2009). Structure of the AML1-ETO eTAFH domain–HEB peptide complex and its contribution to AML1-ETO activity. Blood. 113(15). 3558–3567. 28 indexed citations
20.
Cai, Xiongwei, Ting Xiao, Sharon Y. James, et al.. (2009). Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2. Lung Cancer. 65(3). 299–305. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026